TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cytosorbents ( (CTSO) ) has issued an announcement.
On October 2, 2025, CytoSorbents Corporation received a notice from Nasdaq for non-compliance with the Minimum Bid Price Requirement, as its stock price remained below $1.00 for 30 consecutive business days. The company has until March 31, 2026, to regain compliance by ensuring its stock price meets or exceeds $1.00 for at least 10 consecutive days. Failure to comply could lead to an additional compliance period if an acceptable plan is presented to Nasdaq. The company is actively monitoring its stock price and exploring options to meet the requirement.
The most recent analyst rating on (CTSO) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Cytosorbents stock, see the CTSO Stock Forecast page.
Spark’s Take on CTSO Stock
According to Spark, TipRanks’ AI Analyst, CTSO is a Neutral.
Cytosorbents’ overall stock score is primarily impacted by its challenging financial performance and valuation concerns. While there are some positive aspects in sales growth and restructuring efforts, the regulatory challenges and high debt levels significantly weigh down the score.
To see Spark’s full report on CTSO stock, click here.
More about Cytosorbents
Average Trading Volume: 170,023
Technical Sentiment Signal: Sell
Current Market Cap: $58.56M
Find detailed analytics on CTSO stock on TipRanks’ Stock Analysis page.